A Contract Research Organization (CRO) is a company that offers various types of non-core services on an outsourcing basis to pharma, biotech and medical device companies, as well as research institutions. Their top line includes a very broad range of services covering research and development, clinical trials, regulatory affairs, and data management. Since they accomplish these complicated and time-consuming tasks with fewer resources, CROs are the main agents of cost reductions, acceleration of the drug development process and facilitation of new products’ access to the market. As a result, companies can concentrate on their core business without the need for keeping large in-house teams.
Key Growth Drivers and Opportunities
Rising Prevalence of Chronic Diseases: The CROs market is being expanded by increasing global investments in biotech, healthcare, and pharmaceutical R&D, which is the result of the increasing number of chronic diseases worldwide. These diseases, which are the result of urbanization, unhealthy diets, pollution, and sedentary lifestyles, are the primary causes that lead to the growth of the CRO market.
Challenges
The market for Contract Research Organization (CRO) services is affected by the limitations of high operating costs, stringent regulations, and concerns over data privacy, and dependency on client budgets, which can limit the expansion of the market and delay the schedules of the projects.
Innovation and Expansion
Lindus Health Launches “All-in-One Ophthalmology CRO” Tailored to Clinical Trials in Ophthalmology
In September 2024, the “anti-CRO” that is conducting clinical trials for life science pioneers far more quickly and reliably, Lindus Health, has unveiled its comprehensive contract research organization (CRO) and technology solution for conducting clinical trials in ophthalmology.
Lindus Health has the resources necessary to conduct ophthalmic research in the US, UK, and Europe. Their “All-in-One Ophthalmology CRO” includes the creation of both prescription-grade and over-the-counter (OTC) medications for a wide range of ocular conditions, such as dry eye, diabetic retinopathy, macular degeneration, myopia, and more.
At CPHI Milan, Thermo Fisher Introduced New CDMO and CRO Services
In October 2024, Accelerator Drug Development, Thermo Fisher Scientific’s 360° contract development and manufacturing organization and contract research organization drug development solutions, is being introduced.
The company claims that because Accelerator Drug Development offers clinical supply chain services, clinical research, and customizable manufacturing for small molecules, biologics, and cell and gene treatments, it will have an influence on the pharmaceutical value chain for both biotech and large pharmaceutical companies. The services are designed to help clients at each phase of the drug development process.
Inventive Sparks, Expanding Markets
The key players operating the contract research organizations services market includes, IQVIA Inc., Clintec, Laboratory Corporation of America Holdings, PRA Health Sciences, Inc. Pharmaceutical Product Development LLC., ICON, Syneos Health, Charles River Laboratories International, Parexel International Corporation, Covance Inc. and Medpace Holdings Inc., PSI and KCR CRO among others.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.